Galera Therapeutics, Inc. Financial Ratios — GRTX Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-196.02	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-44.28	-49.12	-71.54	-96.21	-97.72	-168.38	-104.61	1,723.41
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-217.4
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	8.81
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-196.02	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	1	1	- -	- -	1	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	1	- -	- -	- -	1	- -	- -
Total Debt/EBITDA	- -	- -	-0.02	-0.01	- -	- -	-0.03	- -	- -
Net Debt/EBITDA	0.26	0.61	0.36	0.23	0.27	0.08	0.39	0.59	1.06
Total Debt/EBIT	- -	- -	-0.02	-0.01	- -	- -	-0.03	- -	- -
Net Debt/EBIT	0.26	0.61	0.36	0.22	0.27	0.08	0.39	0.59	1.06
EBITDA to Interest Expense	- -	-109.67	-16.64	-14.38	-10.09	-4.42	-4.09	- -	- -
EBITDA-CapEx/Interest Expense	- -	-111.25	-16.84	-14.48	-10.13	-4.42	-4.1	- -	- -
EBIT to Interest Expense	- -	-110.25	-16.72	-14.46	-10.2	-4.43	-4.11	- -	- -
Interest Expense	- -	- -	3	5	7	12	11	- -	- -
Common Equity/Total Assets	-403.27	-119.04	56.42	7.27	-69.62	-247.94	-501.84	-1,465.61	55.23
Long-Term Debt/Equity (%)	- -	- -	0.77	4.84	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	0.76	4.45	-0.08	- -	-0.86	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.43	0.35	0.05	- -	4.27	- -	- -
Total Debt/Equity (%)	- -	- -	1.19	8.73	-0.52	-0.04	-0.95	- -	- -
Total Debt/Capital (%)	- -	- -	1.18	8.03	-0.52	-0.04	-0.96	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.67	0.63	0.36	0.1	4.78	- -	- -
Net Debt to Equity	8.11	14.13	-26.37	-259.43	34.24	3.91	13.92	5.77	-97.31
Net Debt/Capital (%)	7.5	12.38	-35.24	172.15	25.6	3.76	12.32	5.45	-3,622.16
EBITDA	-24	-24	-50	-70	-73	-51	-47	-14	-6
EBITDA-CapEx	-24	-24	-51	-71	-73	-51	-47	-14	-6
Operating Income (Loss)	-24	-24	-51	-71	-73	-51	-47	-14	-6

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.3	12.65	11.58	5.21	5.51	2.36	3.68	4.98	9.88
Current Ratio	3.53	13.01	12.13	5.58	5.98	2.88	4.36	6	11
Quick Ratio	3.42	12.79	11.58	5.21	5.51	2.36	3.68	5.36	9.88
CFO/Avg Current Liab	- -	-4.13	-5.78	-5.03	-5.05	-3.3	-4.89	-3.67	-5.23
Common Equity/Total Assets	-403.27	-119.04	56.42	7.27	-69.62	-247.94	-501.84	-1,465.61	55.23
Long-Term Debt/Equity (%)	- -	- -	0.77	4.84	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	0.76	4.45	-0.08	- -	-0.86	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.43	0.35	0.05	- -	4.27	- -	- -
Total Debt/Equity (%)	- -	- -	1.19	8.73	-0.52	-0.04	-0.95	- -	- -
Total Debt/Capital (%)	- -	- -	1.18	8.03	-0.52	-0.04	-0.96	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.67	0.63	0.36	0.1	4.78	- -	- -
CFO/Total Liabilities	-24.64	-11.49	-86.78	-76.35	-48.09	-28.34	-28.51	-7.9	-937.83
CFO/CapEx	-73.37	-63.88	-73.71	-130.28	-240.13	-1,737.04	-760.14	- -	- -
Altman's Z-Score	-11	-1.58	1.45	-4.04	-7.06	-16.18	-32.46	-66.87	-59.94

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	327	256	121	42	8	3	2
- Cash & Cash Equivalents	6	15	18	16	20	4	18	8	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	4	3
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	1	- -	- -	1	- -	- -
Enterprise Value	-14	-82	215	183	51	11	-9	- -	-2
Total Capital	-76	-105	70	7	-58	-109	-130	-144	7
Total Debt/Capital (%)	- -	- -	1.18	8.03	-0.52	-0.04	-0.96	- -	- -
Total Debt / EV	- -	- -	- -	- -	0.01	- -	-0.14	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	327	254	118	40	6	3	2
Diluted Enterprise Value	-6	-15	309	239	99	36	-11	-1	-2
EV per Share	- -	- -	1,733.55	1,467.51	381.96	76.65	28.77	9.11	4.35
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-24	-24	-50	-70	-73	-51	-47	-14	-6
TTM Operating Income	-24	-24	-51	-71	-73	-51	-47	-14	-6
TTM Cash Flow to Firm	-23	-22	-44	-55	-61	-32	-33	-12	-6
TTM Free Cash Flow to Firm	-23	-22	-43	-54	-60	-32	-33	-12	-6

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-7.09	-4.31	-1.75	-0.93	-0.14	-0.21	-0.36
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-14	-82	215	183	51	11	-9	- -	-2
Low Price	- -	- -	1,632	1,116	238	224	17.06	4.2	3.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	0.01
Price/Earnings Average	- -	- -	-5.83	-3.54	-2.47	-0.8	-1.21	-0.36	0.02
Price/Earnings High	- -	- -	-7.14	-6.53	-4.16	-2.02	-2.71	-0.84	0.04
Price/Earnings Low	- -	- -	-3.9	-1.87	-0.38	-0.49	-0.06	-0.06	0.01
Price/Book Value	- -	- -	4.69	41.76	-2.09	-0.39	-0.06	-0.02	0.42
Price/Book Value Average	- -	- -	4.35	43.16	-3.51	-0.48	-0.66	-0.06	0.53
Price/Book Value High	- -	- -	5.33	79.61	-5.93	-1.21	-1.49	-0.15	1.14
Price/Book Value Low	- -	- -	2.91	22.78	-0.54	-0.29	-0.04	-0.01	0.29
Price/Tangible Book Value	- -	- -	4.91	85.77	-1.99	-0.38	-0.06	-0.02	0.42
Price/Tangible Book Value Average	- -	- -	4.55	88.64	-3.33	-0.47	-0.65	-0.06	0.53
Price/Tangible Book Value High	- -	- -	5.58	163.49	-5.62	-1.18	-1.45	-0.15	1.14
Price/Tangible Book Value Low	- -	- -	3.05	46.78	-0.51	-0.28	-0.03	-0.01	0.29
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-7	-4.27	-1.74	-0.93	-0.14	-0.21	-0.36
Price/Cash Flow Average	- -	- -	-6.48	-4.42	-2.92	-1.14	-1.59	-0.56	-0.45
Price/Cash Flow High	- -	- -	-7.94	-8.15	-4.93	-2.9	-3.57	-1.3	-0.97
Price/Cash Flow Low	- -	- -	-4.34	-2.33	-0.45	-0.7	-0.08	-0.09	-0.25
Price/Free Cash Flow Average	- -	- -	-6.57	-4.45	-2.94	-1.14	-1.59	-0.56	-0.45
Price/Free Cash Flow High	- -	- -	-8.05	-8.21	-4.95	-2.9	-3.57	-1.3	-0.97
Price/Free Cash Flow Low	- -	- -	-4.4	-2.35	-0.45	-0.7	-0.08	-0.09	-0.25
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.26	0.61	-5.65	-3.54	-2.54	-0.94	-1.5	-0.38	0.28
EV/EBITDA High	0.26	0.61	-7	-6.72	-4.47	-2.51	-3.82	-1.27	-0.12
EV/EBITDA Low	0.26	0.61	-3.67	-1.77	-0.16	-0.54	0.26	0.17	0.44
EV/EBIT Average	0.26	0.61	-5.62	-3.53	-2.51	-0.94	-1.49	-0.38	0.28
EV/EBIT High	0.26	0.61	-6.97	-6.69	-4.42	-2.51	-3.8	-1.27	-0.12
EV/EBIT Low	0.26	0.61	-3.65	-1.76	-0.16	-0.54	0.26	0.16	0.44
Last Price	- -	- -	2,632	2,046	918	298	29.08	9.16	4.4
High Price	- -	- -	2,988	3,900	2,598	930	718	58	11.96
Enterprise Value Average	-6	-15	285	249	184	48	70	5	-2
Enterprise Value High	-6	-15	353	472	324	128	178	18	1
Enterprise Value Low	-6	-15	185	124	12	28	-12	-2	-3

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-315.44	-249.23	-406.46	-564.42	-562.94	-377.4	-209.62	-51.74	-12.27
Operating Income per Share	-316.54	-250.54	-408.61	-567.38	-568.98	-378.24	-210.78	-51.81	-12.27
Basic EPS, GAAP	-309.33	-244.56	-418.6	-596.86	-624.55	-459.43	-265.24	-69.4	302.63
Basic EPS from Cont Ops	-309.33	-244.56	-418.6	-596.86	-624.55	-459.43	-265.24	-69.4	302.63
Diluted EPS, GAAP	-309.33	-244.56	-418.6	-596.86	-624.55	-459.43	-265.24	-69.4	302.63
Diluted EPS from Cont Ops	-309.33	-244.56	-418.6	-596.86	-624.55	-459.43	-265.24	-69.4	302.63
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-307.5	-228.96	-376.13	-478.79	-527.02	-320.65	-201.34	-44.46	-12.28
Free Cash Flow per Basic Share	-311.7	-232.55	-381.23	-482.47	-529.22	-320.83	-201.61	-44.46	-12.28
Cash & Equivalents per Share	116.41	669.21	905.15	582.77	538.33	221.66	67.13	21.97	16.9
Book Value per Share	-624.78	-860.52	561.1	48.99	-438.45	-765.91	-482.37	-392.36	10.53
Tangible Book Value per Share	-650.55	-886.29	535.79	23.85	-462.18	-787.93	-493.91	-392.36	10.53

Galera Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)